Reference values for forced vital capacity in idiopathic pulmonary fibrosis

被引：0
|
作者：
Pereira, Carlos A. C. [1 ]
机构：
[1] Univ Fed Sao Paulo, Interstitial Lung Dis Program, Sao Paulo, Brazil
来源：
RESPIRATORY MEDICINE | 2017年 / 125卷
关键词：
D O I：
10.1016/j.rmed.2016.11.022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [41] Predictors of Stability/Improvement of Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis After One Year of Treatment With Nintedanib
    Mondoni, Michele
    Varone, Francesco
    Alfano, Fausta
    Muscato, Giuseppe
    Conti, Caterina
    Saderi, Laura
    Iovene, Bruno
    Di Marco, Fabiano
    Vancheri, Carlo
    Richeldi, Luca
    Centanni, Stefano
    Sotgiu, Giovanni
    ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (07): : 464 - 466
  • [42] First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value
    Wim A. Wuyts
    Martin Kolb
    Susanne Stowasser
    Wibke Stansen
    John T. Huggins
    Ganesh Raghu
    Lung, 2016, 194 : 739 - 743
  • [43] Effect Of Nintedanib On Decline In Forced Vital Capacity (FVC) Over Time In The Inpulsis® Trials In Patients With Idiopathic Pulmonary Fibrosis
    Maher, T. M.
    Flaherty, K. R.
    Azuma, A.
    Cottin, V.
    Stansen, W.
    Quaresma, M.
    Wells, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [44] Relative Versus Absolute Decline in Forced Vital Capacity in Progressive Pulmonary Fibrosis
    Castro, Horacio Matias
    Furcada, Joaquin Maritano
    Enghelmayer, Juan Ignacio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (12): : 843 - 844
  • [45] Reference Values of Forced Vital Capacity and Expiratory Flow in High-Level Cyclists
    Dauty, Marc
    Georges, Thomas
    Le Blanc, Camille
    Louguet, Bastien
    Menu, Pierre
    Fouasson-Chailloux, Alban
    LIFE-BASEL, 2021, 11 (12):
  • [46] Biomarkers Replacing Forced Vital Capacity Testing in Idiopathic Pulmonary Fibrosis: The Views of Physicians in the US Compared to the EU5
    Roche, K.
    Moll, J.
    Phillip, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [47] Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
    Biondini, Davide
    Balestro, Elisabetta
    Lacedonia, Donato
    Cerri, Stefania
    Milaneschi, Rosanna
    Luppi, Fabrizio
    Cocconcelli, Elisabetta
    Bazzan, Erica
    Clini, Enrico
    Barbaro, Maria Pia Foschino
    Gregori, Dario
    Cosio, Manuel G.
    Saetta, Marina
    Spagnolo, Paolo
    SCIENTIFIC REPORTS, 2018, 8
  • [48] Validation of A 25-Gene Blood Transcriptomic Signature Predictive of Forced Vital Capacity Decline in Patients With Idiopathic Pulmonary Fibrosis
    Bonham, C.
    Neely, M. L.
    Huang, Y.
    Ma, S.
    Kim, J. S.
    Oldham, J. M.
    Becker, K.
    Soellner, J.
    Todd, J. L.
    Noth, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [49] Assessing the Therapeutic Response to Pirfenidone in Idiopathic Pulmonary Fibrosis: Can We Do Better than with Forced Vital Capacity Alone?
    Karishma Hosein
    Jamie Le
    Marco Mura
    Lung, 2017, 195 : 101 - 105
  • [50] Stratification of long-term outcome in stable idiopathic pulmonary fibrosis by combining longitudinal computed tomography and forced vital capacity
    Sverzellati, Nicola
    Silva, Mario
    Seletti, Valeria
    Galeone, Carlotta
    Palmucci, Stefano
    Piciucchi, Sara
    Vancheri, Carlo
    Poletti, Venerino
    Tomassetti, Sara
    Karwoski, Ronald
    Bartholmai, Brian J.
    EUROPEAN RADIOLOGY, 2020, 30 (05) : 2669 - 2679
12345